Cantex Pharmaceuticals Announces Article Published in npj Breast Cancer Highlighting Potential Role of RAGE Inhibition to Prevent Metastasis in Triple-Negative Breast Cancer
WBTW News13,
Cantex's once daily, orally administered, azeliragon inhibits interactions of the receptor for advanced glycation end products (R…